Delcath Systems Inc.
Clinical trials sponsored by Delcath Systems Inc., explained in plain language.
-
New Two-Pronged attack on breast cancer in the liver
Disease control Recruiting nowThis study is for people with breast cancer that has spread mainly to the liver. It is testing if a two-step treatment is better than standard drugs alone. First, a special procedure delivers high-dose chemotherapy directly to the liver. Then, patients receive standard chemothera…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New Liver-Targeted attack on stubborn colon cancer
Disease control Recruiting nowThis study is for people with advanced colorectal cancer that has spread mainly to the liver and is no longer responding to standard treatments. It aims to see if a procedure that delivers high-dose chemotherapy directly to the liver, followed by standard oral cancer drugs, works…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC